Tuberculosis infection in patients with rheumatic diseases under different treatments

Tuberculosis infection in patients with rheumatic diseases under different treatments

Objective: To describe the clinical characteristics of the patients with rheumatic disease who develop tuberculosis(TB), this study investigated the clinical characteristics of patients with rheumatic diseases under different treatments. Method: We collected clinical data of patients diagnosed with...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tianhui Liu, Hongxuan Yan, Mengqiu Gao
Format:	Article
Language:	English
Published:	Elsevier 2025-05-01
Series:	Journal of Infection and Public Health
Subjects:	bDMARDs Clinical characteristics Immunosuppressants Rheumatic diseases Tuberculosis
Online Access:	http://www.sciencedirect.com/science/article/pii/S1876034125000528
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Outcomes of children with juvenile idiopathic arthritis receiving biological disease-modifying anti-rheumatic drugs: a retrospective single-centre experience from IndiaResearch in context
by: Pavneet Kaur, et al.
Published: (2025-07-01)

Risk of serious bacterial infections in inflammatory rheumatic or bowel disease patients during biological therapies: nationwide Danish cohort study
by: Emma Cathrine Højberg Platz, et al.
Published: (2025-12-01)

Aging does not impact safety and efficacy of biologic or targeted synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
by: Yasemin Tombak, et al.
Published: (2025-06-01)

Secukinumab Persistence in Patients with Psoriatic Arthritis: An Adalimumab-Matched Retrospective Cohort Database Study (FLYWAY)
by: Hideto Kameda, et al.
Published: (2025-03-01)

Effectiveness and patient-reported impact of on-flare retreatment in patients with rheumatoid arthritis: insights from retrospective long-term real-world data
by: Delphine Bertrand, et al.
Published: (2025-07-01)

Rheumatoid arthritis and COVID-19: Three years later
by: B. S. Belov, et al.
Published: (2023-08-01)

Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region
by: Zoltán Kaló, et al.
Published: (2017-01-01)

Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies
by: Philip J. Mease, et al.
Published: (2024-08-01)

Efficacy of iguratimod in the treatment of patients with palindromic rheumatism ineffective to methotrexate or hydroxychloroquine
by: Mengjie Chen, et al.
Published: (2025-06-01)

Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia
by: E. L. Nasonov, et al.
Published: (2021-07-01)

HEPATITIS B VIRUS AND RHEUMATIC DISEASES
by: B. S. Belov, et al.
Published: (2020-04-01)

QuantiFERON-TB Gold Plus for screening and monitoring latent tuberculosis infection in spondyloarthritis patients
by: Zehra Ozsoy, et al.
Published: (2025-05-01)

Magnetic resonance tomography capabilities and limitations in managing the efficacy of treatment with biological disease modifying anti-rheumatic drugs in ankylosing spondylitis
by: P. A. Shesternya, et al.
Published: (2021-04-01)

Poncet rheumatism secondary to ceco-appendicular tuberculosis in systemic lupus erythematosus
by: Abir Derbel, et al.
Published: (2024-09-01)

Invasive aspergillosis in adult patients with rheumatic diseases
by: V. I. Mazurov, et al.
Published: (2020-11-01)

Rheumatic diseases and viral infection: is there an association?
by: R. M. Balabanova
Published: (2020-11-01)

Is vaccination against viral hepatitis B safe and immunogenic in patients with rheumatic diseases?
by: G. I. Gridneva, et al.
Published: (2024-10-01)

Clinical characteristics and prognostic factors of COVID-19 in rheumatic patients and their family members: a retrospective study
by: Yihua Fan, et al.
Published: (2024-12-01)

Improvement in rheumatoid sarcopenia with biological therapy; muscle ultrasound study
by: Zehra Özsoy, et al.
Published: (2024-11-01)

Comparison of seropositive and seronegative rheumatoid arthritis patients using or about to be initiated with biological DMARDS
by: Zehra Özsoy, et al.
Published: (2025-03-01)

Evolving strategies in the treatment of rheumatoid arthritis: a historical perspective
by: Julia Domańska-Poboża, et al.
Published: (2025-02-01)

Diagnosis and Management of Chronic Nonbacterial Osteomyelitis in a Dog
by: Young-Sun Jeong, et al.
Published: (2025-05-01)

Perioperative management with DMARDs in rheumatic diseases: a scoping review of clinical guidelines
by: Alice Terrett, et al.
Published: (2025-07-01)

Lower respiratory tract infections in rheumatic diseases
by: B. S. Belov, et al.
Published: (2018-04-01)

Iguratimod efficacy in palindromic rheumatism treatment
by: Fangfang Yuan, et al.
Published: (2023-06-01)

Correlation between the morphological signs of tuberculosis and the immune status in HIV infection
by: Yu. R.  Zyuzya, et al.
Published: (2014-11-01)

Primer on the Rheumatic Diseases /
Published: (1993)

Lobular panniculitis in rheumatic diseases: the authors’ own data
by: O. N. Egorova, et al.
Published: (2020-03-01)

COVID-19 and Rheumatic Diseases in Tamil Nadu – A multicenter retrospective observational study
by: Sowndhariya V Annamalai, et al.
Published: (2021-01-01)

Methotrexate in the treatment of rheumatic disease
by: Marina Zinovyevna Kanevskaya, et al.
Published: (2013-12-01)

Treating rheumatoid arthritis in Zanzibar: a cost effectiveness study comparing conventional, biologic, and targeted-synthetic disease modifying anti-rheumatic drugs
by: Sanaa S. Said, et al.
Published: (2025-08-01)

TARGETED THERAPY AND INFECTIONS IN RHEUMATIC DISEASES
by: B. S. Belov, et al.
Published: (2016-12-01)

Chronic hepatitis B in hospitalized rheumatologic patients: problems of screening and reactivation of infection
by: G. I. Gridneva, et al.
Published: (2023-10-01)

PERIPROSTHETIC JOINT INFECTION IN PATIENTS WITH RHEUMATIC DISEASES: THE PROBLEMS OF DIAGNOSIS, PREVENTION, AND TREATMENT
by: A. E. Khramov, et al.
Published: (2015-10-01)

Mycobacterium tuberculosis in patients with hematologic malignancies in a low-risk setting
by: L. Mezzadri, et al.
Published: (2025-06-01)

Chronic and opportunistic infections in patients with immuno-inflammatory rheumatic diseases: screening and prevention issues (based on the materials of the EULAR recommendations)
by: B. S. Belov, et al.
Published: (2023-03-01)

A mini review of the pathogenesis of acute rheumatic fever and rheumatic heart disease
by: Shuting Zhuang, et al.
Published: (2025-04-01)

Treatment of rheumatic diseases. Different nosologies, common problems
by: Yu. A. Olyunin
Published: (2023-04-01)

Safety and efficacy of 23-valent polysaccharide pneumococcal vaccine in patients with systemic lupus erythematosus
by: G. M. Tarasova, et al.
Published: (2021-06-01)

Complications of invasive oral procedures in patients with immune-mediated inflammatory disorders treated with biological and conventional disease-modifying antirheumatic drugs or glucocorticoids: a scoping review of the literature
by: Loredana Radoi, et al.
Published: (2025-03-01)